$2.00+0.00%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Inhibikase Therapeutics last closed at $2.00 (+0.00%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -5.8×. Its overall grade ranks 283 of 741 stocks in Healthcare.
About this company
Inhibikase Therapeutics last closed at $2.00 (+0.00%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 283/741
Valuation grade A
Related stocks
- NovartisCompetitor
파킨슨병·신경퇴행성 질환 치료제 개발에서 경쟁 가능성이 큰 글로벌 제약사
- AbbVieCompetitor
신경과/염증·면역 질환 파이프라인을 보유한 대형 제약사로 경쟁 환경에 영향
- RocheCompetitor
중추신경계 질환 및 바이오의약품 분야의 대형 경쟁사
About Inhibikase Therapeutics
- What technical signals does Inhibikase Therapeutics (IKT) have?
- Inhibikase Therapeutics current technical signals: no active technical signal.
- Is Inhibikase Therapeutics a cup-and-handle pattern?
- No. Inhibikase Therapeutics has no valid Cup signal right now.
- What published figures are available for Inhibikase Therapeutics?
- Market cap: $241.8M. Trailing 12 months PER: -5.8×. Latest quarter PBR: 2.28×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Inhibikase Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy